Douglas J Swirsky
CIK 1375884 · CHIEF FINANCIAL OFFICER · last filed 2026-03-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$225.6K
Companies
8
Total Filings
55
Lifetime Open-Market Net
$206.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MXCT | CHIEF FINANCIAL OFFICER | 151,669 | $1.12 | $169.9K | $34.2K | 6 | 2026-03-19 |
| CLRB | Director | 25,000 | $2.23 | $55.8K | $26.0K | 6 | 2025-02-18 |
| MetaVia Inc. (NRBO) Delisted | Director | — | $2.36 | — | $0 | 1 | 2020-09-03 |
| Cellectar Biosciences, Inc. (CLRBZ) Delisted | Director | — | $0.12 | — | $0 | 4 | 2020-06-25 |
| Fibrocell Science, Inc. (FCSC) Delisted | Director | — | — | — | $0 | 7 | 2019-12-13 |
| Opus Genetics, Inc. (RNN) Delisted | President and CEO | 50,000 | — | — | $31.7K | 3 | 2019-01-30 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Director | — | — | — | $0 | 2 | 2018-05-23 |
| GENVEC INC (GNVC) Delisted | President & CEO | 252,500 | — | — | $114.1K | 20 | 2016-09-16 |
Recent Filings · Page 3 of 6
55 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-21 | Fibrocell Science, Inc. (FCSC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-23 | PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-04 | Opus Genetics, Inc. (RNN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-11-17 | PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-26 | Fibrocell Science, Inc. (FCSC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-20 | — | Mixed | −25,250 | -$10.5K | |
| 2017-06-01 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-09-16 | GENVEC INC (GNVC) Delisted | Buy (P) | +10,000 | $5.0K | EDGAR |
| 2016-06-23 | Fibrocell Science, Inc. (FCSC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-02-01 | GENVEC INC (GNVC) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.